Internal medicine journal
-
Internal medicine journal · Dec 2022
National Audit of a Hereditary and Acquired Angioedema Cohort in New Zealand.
Hereditary angioedema (HAE) leads to significant morbidity and mortality from unpredictable intermittent peripheral, abdominal and laryngeal swelling. Access to appropriate healthcare and effective therapies, which can prevent and treat attacks, reduce the suffering and greatly improve quality of life. Although treatments such as C1 inhibitor (Berinert), and Icatibant are available in New Zealand (Aotearoa), there are no published data available on their use. ⋯ Corrective actions arising from this audit will improve our capacity to provide long-term care for HAE patients and their families.
-
Internal medicine journal · Dec 2022
Safety, satisfaction, and cost savings of accelerated infusions of standard and intensified-dose infliximab for inflammatory bowel disease.
Infliximab remains a mainstay for the treatment of inflammatory bowel disease (IBD), but a long infusion duration and subsequent monitoring can be burdensome to patients and healthcare providers. ⋯ Accelerated infliximab infusions for standard and dose-intensified regimens seem to be safe and improved patient satisfaction. Potential impact on drug trough levels requires further investigations.
-
Internal medicine journal · Dec 2022
'So near and yet so far': the early women of the Royal Australasian College of Physicians - the first 20 female MRACP 1938-1947.
At the time of the inauguration of the Royal Australasian College of Physicians in 1938, there were 232 Foundation Fellows, but only five were women. Those who wished to gain a postgraduate qualification for internal medicine or related specialties then sat for Membership of the new College. In the first decade (1938-1947), 250 gained Membership, but only 20 were women. ⋯ Still, they all showed great determination and contributed significantly to their chosen fields, while many combined a busy practice with family life. They improved the path for those women who followed. Their stories, however, are rarely reported.